ISLAMABAD: (HRNW) The National Institute of Health (NIH) has issued an advisory regarding prevention and control of the extensively drug-resistant (XDR) typhoid fever.
The NIH has advised health officials across the country to be prepared timely for prevention and control of the extensively drug-resistant typhoid fever.
Health authorities in the country have reported an outbreak of the XDR typhoid fever that began in the country in November 2016. The outbreak has spread to provinces throughout the country, and several deaths have been reported.
This strain of Salmonella Typhi does not respond to most third generation antibiotics used to treat typhoid fever (ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole, ciprofloxacin, and ceftriaxone), according to the NIH advisory.
Be the first to comment on "NIH issues advisory for Drug-Resistant Typhoid fever infection"